Belding India to seek direct listing of equity shares on NSE Main Board

Capital Market Events View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.0%Reaction day

₹1060.40

prior close

₹1020.00

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.1%-3.9% vs market

Aluminium, Copper & Zinc Products peers, median of 6sector+0.7%-5.7% vs sector

On the reaction day the stock moved 3.9 pts less than Nifty Microcap 250 and 5.7 pts less than its Aluminium, Copper & Zinc Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

+0.0

15m

+0.0

30m

-0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.0-1.1-3.9+0.7-5.7

Next day

-5.0-0.5-4.6+2.1-7.1

-7.6-0.1-7.5+2.0-9.5

-2.9-1.3-1.5+0.8-3.7

-3.0-2.0-1.0-1.4-1.5

-5.7-1.6-4.1+2.0-7.7

-9.0-1.5-7.5+3.0-12.0

15d

-6.0+2.9-8.9+8.1-14.1

-9.1+3.4-12.5+5.5-14.6

-8.5+2.5-11.0——

—-0.1—+7.5—

UpDownMarket · Nifty Microcap 250Sector · Aluminium, Copper & Zinc Products peers, median of 6Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Belding India (formerly Synthiko Foils), currently listed on BSE under scrip code 513307, has approved a proposal to directly list its existing equity shares on the Main Board of NSE. The Board passed the decision via a circular resolution on July 17, 2026. The listing will require approvals from NSE and other regulators. The company said it will start the application process and share further updates.

Likely market impact

Could improve trading liquidity and visibility by adding NSE access for investors; subject to regulatory approvals.